USPTO 2015–2025 USPTO PatentsView US Corporation

Corvia Medical, Inc.

USPTO PatentsView assignee record - 35 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Corvia ranks #9,012 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 10 technology areas.

#9,012
of 49,997 US assignees by volume
46th percentile
by Innovation Score (33.9/100)
14.8
avg claims per patent
+0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9012 · US Corporation #9,012 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 35 grants
  • UPPER-Q #9,012/49,997
  • PHOTO-FINISH Carlsmed
  • CPC-FOCUS A61B · 10 areas
  • INNOV-THIN 33.9/100
  • CLAIMS-RICH 14.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT +0% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Carlsmed, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Corvia’s 33.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Corvia

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Corvia's Innovation Score is 33.9/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Corvia?

Each dot is one of Corvia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Corvia’s own 14.8 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Corvia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 34.935.035.03535.035.035.1 0102030 Granted patents (volume) Avg claims / patent Cixi Huazhijie Plastic Product Co., Ltd. - 35, 1.23Cixi Huazhijie Pl…CJ CGV Co., Ltd. - 35, 11.8CJ CGVCnrs-centre National DE LA Recherche Scientifique - 35, 14.89Cnrs-centre Natio…Code Systems Corporation - 35, 17.71Code SystemsCarlsmed, Inc. - 35, 26.37CarlsmedChildren's Hospital Los Angeles - 35, 17.06Children's Hospit…China Energy Investment Corporation Limited - 35, 16.8China Energy Inve…Cista System Corp. - 35, 18.31Cista SystemCorvia Medical, Inc. - 35, 14.83Corvia Medical
Corvia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Corvia's grants concentrate

Corvia Medical, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 77.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2015. By volume, Corvia sits between Cixi Huazhijie Plastic Product Co., Ltd. and Cista System Corp..

Corvia's three-year grant acceleration

Corvia Medical, Inc. shows 4 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Corvia's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Corvia holds 35 patents at rank #9,003, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Corvia

By rank, the assignees closest to #9,003 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Corvia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Corvia, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Corvia ranks #686 of 7,127 assignees by patent count in that subclass.

Corvia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2015201620172018201920202021202220232025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Corvia Medical, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 2.9%
2016 4 11.4%
2017 4 11.4%
2018 2 5.7%
2019 6 17.1%
2020 7 20.0%
2021 6 17.1%
2022 1 2.9%
2023 3 8.6%
2025partial year 1 2.9%

Which technologies does Corvia Medical, Inc. patent most?

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Corvia Medical, Inc.'s patent record in context - here's where to go next.

  • Corvia Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 77.1% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #9,012 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Corvia Medical, Inc. against Cixi Huazhijie Plastic Product Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.